Navidea Biopharmaceuticals is a biopharm company focused on the development and commercialization of precision diagnostic agents. NAVB’s radiopharmaceutical development programs include Lymphoseek, a radiopharmaceutical agent for lymph node mapping; AZD4694, an imaging agent; and RIGScan, a tumor antigen-specific targeting agent. The company has a license agreement for Altropane, being developed as an aid in the diagnosis of Parkinson’s disease, movement disorders and dementia. For further information, visit the company’s Web site at www.navidea.com

EBD Group’s Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event.

Let us hear your thoughts below: